Filing Flows

Filing Flows › Concentrix (CNXC) › Q2 FY26

Concentrix (CNXC) Q2 FY26 earnings results (second quarter fiscal 2026)

10-Q filed Jul 2, 2026

Concentrix (CNXC) reported revenue of $2.5B for the second quarter fiscal 2026 (Q2 FY26), +2% from a year earlier and -2% from the quarter before. Operating margin was 3.9%, net earnings $55.3M (2.2% of revenue).

Revenue$2.5B
Year over year+2%
Quarter over quarter-2%
Operating margin3.9%
Net earnings$55.3M

Concentrix, Q2 FY26: revenue $2.5B (+2% year over year), operating margin 3.9%, net earnings $55.3M, operating cash flow $258M. The chart follows the revenue to costs, profit and cash.

Q2 FY26AmountQ/QY/Y
Revenue$2.5B-2%+2%
Gross profit$823M-3%-3%
Operating profit$95.4M-20%-36%
Net earnings$55.3M+156%+31%
Operating cash flow$258M—+9%
Free cash flow$210M—+16%

What changed

Revenue was $2.5B in Q2 FY26, up 2% year over year and down 2% from the previous quarter.

Gross margin was 33.4%, down 1.6 points from Q2 FY25. Operating profit was $0.10B, a 3.9% margin (down 2.3 points year over year). Operating profit fell $0.05B even though revenue rose $0.05B versus Q2 FY25, so costs grew faster than sales. Operating expenses grew 4% against revenue growth of 2%. Net earnings were $0.06B, up 31% year over year. The effective tax rate was 20.4%.

Operating cash flow was $0.26B (up 9% year over year), 467% of net earnings. Non-cash charges added back $0.16B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items added $0.02B. After purchases of property and equipment ($0.05B), free cash flow as the company reports it was $0.21B.

Questions

What was Concentrix's revenue in the second quarter fiscal 2026?

Concentrix (CNXC) reported revenue of $2.5B for the second quarter fiscal 2026 (Q2 FY26), +2% from a year earlier and -2% from the quarter before.

Was Concentrix profitable in the second quarter fiscal 2026?

Operating profit was $95.4M (3.9% of revenue) and net earnings $55.3M.

Open the interactive Sankey →

Source: Concentrix 10-Q on SEC EDGAR.